Chemistry and Industry - Challengers to Acomplia
Tuesday, December 30th, 2008Sanofi-Aventis’ new anti-obesity drug could be facing. challenges from generics before it is even approved in mator developed countries reports the French newspaper Les Echos. Three pharmaceutical companies in India have developed generic versions of the fat-fighting drug Acomplia for the Indian market.
Related Results
Acomplia on trialAcomplia.(Brief article)FDA committee rejects Acomplia due to suicide risksNew Innovative Medi…
